Overview
Sodium iodide is a water-soluble ionic compound with a crystal lattice. Sodium iodide is a source of iodine and can be administered as a supplement for total parenteral nutrition but is more commonly used in veterinary medicine. Radiolabelled compound, Iodide I-131, is used as a diagnostic tool to evaluate thyroid function and morphology.
Indication
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN) .
Associated Conditions
- Abscesses
- Bleeding of the Vitreal Body
- Clouding of the Lenses
- Vitreous opacities
- Wound
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/04/08 | Phase 3 | Completed | |||
2020/06/12 | Phase 2 | Terminated | |||
2018/03/20 | Phase 2 | Completed | |||
2008/03/18 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Perrigo Direct, Inc. | 50804-088 | TOPICAL | 20.4 mg in 1 mL | 9/17/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| ANSTO - Sodium Iodide [131I] Therapy Capsules (50 to 6000 MBq) | SIN16117P | CAPSULE | 50 to 6000 MBq/capsule | 3/8/2021 | |
| SODIUM IODIDE NA131I POLATOM CAPSULE | SIN15467P | CAPSULE | 37-5500 MBq | 4/23/2018 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| SODIUM IODIDE INJ 100MG/ML | sabex inc | 00807680 | Liquid - Intravenous | 100 MG / ML | 12/31/1988 |
| SCLERODINE 6 INJECTION | omega laboratories limited | 02020793 | Liquid - Intravenous | 90 MG / ML | 12/31/1977 |
| NATRUM IODATUM GRAN AND GLOB 5CH-30CH | dolisos laboratoires s.a. | 00747157 | Tablet - Oral | 1 DH / TAB | 12/31/1987 |
| PARAMETTES ADULTS | whitehall-robins inc. | 02031604 | Tablet - Oral | .2 MG / TAB | 12/31/1993 |
| NATRUM IODATUM DROPS 5CH-30CH | dolisos laboratoires s.a. | 00747165 | Drops - Oral | 1 DH / DH | 12/31/1987 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.